首页 | 官方网站   微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   5134074篇
  免费   385639篇
  国内免费   16226篇
医药卫生   5535939篇
  2021年   57317篇
  2019年   59656篇
  2018年   77191篇
  2017年   59246篇
  2016年   65674篇
  2015年   77919篇
  2014年   112294篇
  2013年   178354篇
  2012年   147756篇
  2011年   156939篇
  2010年   133666篇
  2009年   132560篇
  2008年   141930篇
  2007年   152772篇
  2006年   159543篇
  2005年   153374篇
  2004年   153810篇
  2003年   143134篇
  2002年   131970篇
  2001年   209829篇
  2000年   206557篇
  1999年   184437篇
  1998年   77241篇
  1997年   71293篇
  1996年   69209篇
  1995年   64697篇
  1994年   58561篇
  1993年   54190篇
  1992年   134764篇
  1991年   129184篇
  1990年   124483篇
  1989年   121091篇
  1988年   111308篇
  1987年   108972篇
  1986年   102654篇
  1985年   99849篇
  1984年   80502篇
  1983年   70745篇
  1982年   52354篇
  1981年   48302篇
  1980年   45152篇
  1979年   69662篇
  1978年   54084篇
  1977年   47815篇
  1976年   44316篇
  1975年   45168篇
  1974年   50410篇
  1973年   48330篇
  1972年   45226篇
  1971年   41951篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
61.
ABSTRACT

A monocausal bacteriological understanding of infectious disease orients tuberculosis control efforts towards antimicrobial interventions. A bias towards technological solutions can leave multistranded public health and social interventions largely neglected. In the context of globalising biomedical approaches to infectious disease control, this ethnography-inspired review article reflects upon the implementation of rapid diagnostic technology in low- and middle-income countries. Fieldwork observations in Vietnam provided a stimulus for a critical review of the global rollout of tuberculosis diagnostic technology. To address local needs in tuberculosis control, health managers in resource-poor settings are readily cooperating with international donors to deploy novel diagnostic technologies throughout national tuberculosis programme facilities. Increasing investment in new diagnostic technologies is predicated on the supposition that these interventions will ameliorate disease outcomes. However, suboptimal treatment control persists even when accurate diagnostic technologies are available, suggesting that promotion of singular technological solutions can distract from addressing systemic change, without which disease susceptibility, propagation of infection, detection gaps, diagnostic delays, and treatment shortfalls persist.  相似文献   
62.
63.
64.
65.
66.
67.
68.
69.
70.

Background

Nursing Home Compare (NHC) ratings, created and maintained by Medicare, are used by both hospitals and consumers to aid in the skilled nursing facility (SNF) selection process. To date, no studies have linked NHC ratings to actual episode-based outcomes. The purpose of this study was to evaluate whether NHC ratings are valid predictors of 90-day complications, readmission, and bundle costs for patients discharged to an SNF after primary total joint arthroplasty (TJA).

Methods

All SNF-discharged primary TJA cases in 2017 at a multihospital academic health system were queried. Demographic, psychosocial, and clinical variables were manually extracted from the health record. Medicare NHC ratings were then collected for each SNF. For patients in the Medicare bundle, postacute and total bundle cost was extracted from claims.

Results

Four hundred eighty-eight patients were discharged to a total of 105 unique SNFs. In multivariate analysis, overall NHC rating was not predictive of 90-day readmission/major complications, >75th percentile postacute cost, or 90-day bundle cost exceeding the target price. SNF health inspection and quality measure ratings were also not predictive of 90-day readmission/major complications or bundle performance. A higher SNF staffing rating was independently associated with a decreased odds for >75th percentile 90-day postacute spend (odds ratio, 0.58; P = .01) and a 90-day bundle cost exceeding the target price (odds ratio = 0.69; P = .02) but was similarly not predictive of 90-day readmission/complications.

Conclusion

Results of our study suggest that Medicare's NHC tool is not a useful predictor of 90-day costs, complications, or readmissions for SNFs within our health system.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号